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We have reported previously that striatal projection neurons are differentially affected in the course of Huntington's 
disease, and in a prior patient report we noted that differential loss of striatal projection neurons occurs also in patients 
with presymptomatic Huntington's disease. Striatal neurons projecting to the external segment of the globus pallidus 
or the substantia nigra show evident loss, whereas those projecting to the internal segment of the globus pallidus 
appear relatively spared at presymptomatic and early stages of symptomatic Huntington's disease. We now report 
similar findings in a second apparently presymptomatic Huntington's disease allele carrier. 
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The histopathological hallmark of Huntington's disease 
(HD) is pronounced atrophy of the striatum, especially 
the caudate nucleus. Within the striatum, there is dif- 
ferential involvement of subpopulations of striatal neu- 
rons. Striatal interneurons cocontaining the peptides 
somatostatin and neuropeptide Y and the enzyme 
NADPH-diaphorase appear to be spared in patients 
with HD 11, 2). Similarly, the perikarya of striatal cho- 
linergic interneurons appear also to be spared [ 3 ,  41, 
though there is an impressive loss of striatal choline 
acetyltransferase activity and of cholinesterase staining 
within the striatum [ 5 ,  61. These classes of striatal in- 
terneurons comprise only a small fraction of all striatal 
neurons. The overwhelming majority of striatal neu- 
rons are projection neurons, and striatal projection 
neurons are markedly depleted in the course of HD. 
Striatal projection neurons are subdivided into sepa- 
rate populations based on their projection targets and 
neuropeptide content 17- 13f. Striatal neurons pro- 
jecting to the external segment of the globus pallidus 
(GPe) are enriched in enkephalins (ENK), whereas 
striatal neurons projecting to the internal segment of 
the globus pallidus (GPi) or to the substantia nigra 
(SN) are enriched in substance P (SP) 112, 13). We 
have shown previously that ENK-containing striatal 
neurons projecting to the GPe and SP-containing stria- 
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tal neurons projecting to the SN are preferentially de- 
pleted in early grade HD with relative preservation of 
SP-containing striatal neurons projecting to the GPi 
[14].  By late grade HD, all striatal projection neurons 
show extensive loss. This sequence of striatal projec- 
tion neuron loss is correlated with the evolution of 
some clinical features of HD 114, 151. We have also 
reported abnormalities of striatal projection neurons 
similar to those of early grade HD in a presymptomatic 
carrier of the HD allele [16). We now report preferen- 
tial loss of striato-external pallidal projection neurons 
in a second presymptomatic carrier of the HD allele. 
Case Report and Methods 
Case Report 
The subject was a man from a family with several individuals 
afflicted with typical Huntington's disease. His birth, devel- 
opment, adolescence, and early adulthood were apparently 
normal. An excellent athlete, he was offered and declined a 
college baseball scholarship. After graduation from high 
school, he served in the military for 4 years and was honor- 
ably discharged. He subsequently went into the roofing busi- 
ness with one of his reiatives. Two to 3 years before his 
death, family and friends noticed changes in his personality. 
Formerly a pleasant and agreeable individual, he became un- 
predictably temperamental and argumentative, and some- 
times physically violent. H e  began to use over-the-counter 
Received May 16, 1991, and in revised form Aug 22 .  Accepted for 
publication Sep 26, 1091. 
Address correspondence to Dr Albin, Neuroscience Laboratory 
Building, 1103 E. Huron, Ann Arbor, MI 48104. 
Copyright 0 1992 by the American Neurological Association 425 
stimulants frequently but did not abuse illicit drugs. H e  con- 
tinued to work as a roofer until the time of death and his 
ability to work was unimpaired. Specifically, there was no 
clumsiness. incoordination, or decrease in his rate of work. 
No adventitious movements were noted by friends or family 
members. His  father did notice that he had become some- 
what fidgety and had difficulty sitting still. N o  relative, includ- 
ing those involved in the care of family members suffering 
from HD, noticed any movements that resembled chorea. 
At the age of 28 years, in the course of an argument, he was 
killed by a gunshot to the trunk. 
After appropriate clearances, an autopsy was performed 
approximately 20 hours after death. The brain was removed 
in the routine fashion and hemisected in the midsagittal 
plane. One-half was fixed in 10%' neutral buffered formalin 
and the other one-half frozen to -80°C immediately after 
removal. After 14 days of fixation, the formalin-fixed half 
was cut up into I-cm-thick coronal sections and selected tis- 
sue blocks were prepared for routine light microscopic study. 
Blocks through the pallidum and nigra were used for immu- 
nohistochemical analysis after 6 additional months in fixative. 
Neuropathological analysis was performed by one of the 
authors (W.O.W.) several months before assessment of HD 
allele status. In a thorough survey of the cerebral cortex, 
subcortical white matter, basal ganglia, thalamus, midbrain, 
pons, medulla, and cerebellum, there were no significant neu- 
ropathological abnormalities. Specifically, there was no evi- 
dence of caudate or  cerebral cortical atrophy, no obvious loss 
of striatal neurons, and no striatal or cortical gliosis. Masson 
trichrome-stained sections confirmed the absence of striatal 
gliosis. 
Method 
LINKAGE ANALYSIS. Most members of this pedigree were 
examined for evidence of HD by two of the authors (R.L.A. 
and L.S.D.) and blood samples were drawn for use in linkage 
analysis. D N A  was extracted from the blood samples of 
members and from a frozen block of cerebellar cortex of the 
subject using standard techniques. The entire family study, 
including extraction of D N A  from brain and blood samples, 
was performed in duplicate by two independent technicians. 
Southern blots were generated using appropriate restriction 
enzymes for the following informative polymorphic D N A  
markers that are known to  be closely linked to the HD gene: 
pK082/HidI l I ,  Y N Z ~ ~ I P J - ~ .  and BS674IAciI. The re- 
sulting genotypes at these markers for each relevant member 
of the Family were coded into the MLINK function of the 
LINKAGE progrnm { 171. N o  recombination events were 
observed among the nine informative meiodc events scored. 
All markers were conservatively placed at 2(% recombination 
distance from the H D  locus; these values for theta were 
combined with ages of onset and liability classes for each 
family member to calculate an assessment of accuracy for 
gene-carrier status of the  subject. 
IXtML"OH1SI'OCHEMISI'KY. The integrity of specific types 
of striatal projection neurons was examined by immunohis- 
tochemical staining of their terminals for ENK and SP in 
coronal sections of the pallidum and substantia nigra. 
Well-ch;tracterizeci antisera directed against Leu-enkephalin 
(dilution, 1 : 500; INCstar, Stillwater. MN), met-enkephalin- 
Arg6-Gly--LeuX (dilution, 1 :500; gift of Dr G. J .  Dockray), 
and SP (dilution, 1 : 1,000; Accurate Chemical and Scientific-, 
Westbury, NY) were used, and immunohistochemistry was 
performed using the peroxidase-antiperoxidase technique as 
previously described [ 141. Striatal gliosis was assessed with 
glial fibrillary acidic protein (GFAP) immunoreactivity using 
a well-characterized antiserum (INCstar; 1/500). 
The extent of the reduction of immunohistoc-hem.ically 
stained fibers in G P  and SN was determined with quantita- 
tive image analysis, using a Newvicon camera, video capture 
board, MacIIci computer, and software called Image (devel- 
oped by Wayne Razband, National Institutes of Hedth.  
Bethesda, MD). Thresholding techniques { 181 were used to 
measure fiber abundance in the presymptomatic brain com- 
pared with control subjects. Nine fields of the GPe, 18 jields 
of the GPi, and five fields of the nigra of a single section of 
the presymptomatic subject and control sections matched for 
level of the neuraxis were viewed with a 40  x objective. and 
the gray scale adjusted to maximize contrast between labeled 
fibers and unstained background. Gray scale thresholds 'were 
set to "extract" labeled fibers by removing pixels with gray 
scale values between the thresholds from the image. The area 
of the removed pixels was computed and fiber abundance 
expressed as the area of extracted pixels divided by the total 
area of the field. ENK-immunoreactive (IR) fiber abundance 
in the GPe and SP-IR fiber abundance in GPi and nigra 
were compared with fiber abundance determinations in four 
control subjects matched for time in fixative. Time in fixa.tive 
is a crucial variable affecting the intensity of staining of striatal 
efferent fibers (A. Reiner and colleagues, unpublished data). 
Threshold analysis of GPe ENK-IR fiber abundance and 
SP-IR fiber abundance in the GPi and nigra was also per- 
formed on the previously reported presymptomatic specimen 
and three additional control subjects. 
Results 
Linkuge Analysis 
Results of the linkage analysis revealed a 97% proba- 
bility that the subject was a carrier of the HD dele .  
Imrnunobistocbemist~ 
GFAP staining of the striaturn revealed no increase 
in GFAP imrnunoreactivity cornpared with control 
striaturn. 
In normal pallidum, dendrites of pallidal neurons axe 
coated with the intensely irnrnunoreactive terminals of 
striatopallidal neurons, giving the pallidal dendrites the 
so-called woolly fiber appearance (191 (Figs 1 ,  2). In 
the pallidurn of the presyrnptornatic individual, SP-I R 
woolly fibers in the GPi were normal in appearance, 
but there was a reduction in the number of terminals 
of ENK-IR fibers in the GPe (see Figs 1, 2). A slight 
loss of SP-IR fibers was observed in the SN of the 
presyrnptomatic individual (see Figs 3 ,  2). Threshold 
analysis of fiber abundance in the presyrnptomatic indi- 
vidual confirmed these observations. SP-IR fiber abun- 
dance in the GPi was 74.49  of control; ENK-IR fiber 
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F i g  1 .  The pallidum and substantia nigra of the presymptom- 
atic subject and a control specimen. Substance P-immunoreactiu- 
ity (SP) in the internal segment of the globus pallidus (GPi) of 
the presymptomatic is indistinguishable from normal but 
slightly reduced in  the substantia nigra (SN).  Enkephalin- 
imrnunoreactivity (ENKI in the external segment of the globus 
pallidus IGPe) of the presymptomatic subject is also 1e.u than 
normul. The control specimen and pres-ymptomatic specimen sec- 
tions are at similar levels o f  the neuraxis and the pallidum of 
the presymptomatic specimen appears atrophic. The existence o j  
pallidal (or nigral shrinkage) cannot be assessed without uolu- 
metric measurements . 
NORMAL PRESYMPTOMATIC 
F i g  -3 High-pou er photomicrographr ionzparrng enkephalin- 
tmmiinowactiie (ENKI  fiber labeling i n  the external segment of 
the globits pallidni tG Pr i  u i th ii4htance P-immunoreactm 
ISPI fiber btarnrng in the znternal cegment of the globus pd'idus 
(GPII  in  the subpt  (4 t h i ~  rtport dnd a control sirbject The 
densttl of ENK-immunoreactrz e fiber! tr reduted uhen compared 
u ith the control r?ibject. uherear the drncity o j  SP-~mmzrnoreai- 
tiw fibers t j  comparable u ith the tontrof  iubject Cnmpariion o/ 
f iben labeitd for  SP in the nrgra of the. pmjmptomcrtic bublect 
and control siihjeit indicate u slight redurtion zw fiber abiin- 
dance in the nigra ofthe prejymptomaitc ~ u b p t  
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density in the GPe was 72.8% of control; SP-IR fiber 
density in the SN was 88.9% of control. The variance 
of fiber abundance in control specimens was quite 
small; the standard deviations of SP-IR fiber abundance 
in the GPi was 4.8% and that of ENK-IR fiber abun- 
dance in the GPe was 11%. Threshold analysis of the 
previously reported presymptomatic case and controls 
gave very similar results. SP-IR fiber density in the GPi 
was 94.5% of control; ENK-IR fiber density in the 
GPe was 76.5%, of control; SP-IR fiber density in the 
SN was 86.9% of control. The standard deviation of 
ENK-IR fiber abundance in control GPe was 1.7% 
and of SP-IR fiber abundance in control GPi was 1.9%. 
nals. Shrinkage effects are of especial importance in 
analyzing nigral SP-IR fibers. In our prior studies of 
patients with H D  and presymptomatic HD, changes in 
nigral SP-IR fiber density were accompanied by reduc- 
tion of the area of the nigra containing SP-IR fibers. In 
this presymptomatic specimen, there were only subtle 
changes in either nigral SP-IR area or nigral SP-IR fiber 
density, suggesting that in this individual, striatonigral 
projection neurons are less affected than striato-GPe 
projection neurons. It is possible that the degenera- 
tion of striato-GPe neurons begins before the de- 
generation of striatonigral neurons. Although our 
immunohistochemical results most likely reflect the de- 
generation of striatal projection neurons, we cannot 
exclude the possibility that the perikarya of striato-GPe 
and striatonigral projection neurons are intact but have 
lost the ability to synthesize these neuropeptides. 
Discussion 
The immunohistochemical findings in this presymp- 
tomatic carrier of the HD allele are similar to those 
previously documented in pathologically verified early 
grade HD and similar to that in a prior subject with 
presymptomatic HD C14, 161. These results provide 
further confirmation that degeneration of striatal neu- 
rons projecting to the GPe occurs earlier in the course 
of HD than loss of neurons projecting to the GPi. 
The available clinical information does not allow cer- 
tain assessment of the subject’s clinical status. The his- 
tory of personality changes would be typical of early 
HD, though such changes often occur years in advance 
of a clinically apparent movement disorder [20}. No 
family member noted any adventitious movements or 
impairment of coordination, and no family member felt 
that the subject had chorea. The history of difficulty in 
sitting still, however, is suggestive of subtle chorea. 
The clinical criteria for diagnosis of HD require the 
presence of an unequivocal movement disorder {20], 
and consequently, we classify this individual’s condition 
as presymptomatic. Even if the subject had chorea and 
In conclusion, we have shown changes in striato- 
GPe projection neurons in a presymptomatic carrier 
of the HD allele that are consistent with our previous 
data indicating preferential and presymptomatic loss of 
striato-GPe and striatonigral projection neurons in 
HD. 
This work was supported by NS01300 (R.L.A.), NS19613 (A.B.Y. 
and J.B.P.), NS19620 (A.R.), NS28721 (A.R.), The Hereditary Dis- 
case Foundation (K.D.A.), The Neuroscience Cenrer for Excellence 
of the University of Tennessee (K.D.A.), and the Hunrington’s Dis- 
ease Society of America (L.S.D.). 
We are very grateful to the family of this subject for their coopera- 
tion and support. We also thank Dr  Charles Harlan, Davidson 
County (TN) Medical Examiner for his cooperation in the perfor- 
mance of the autopsy. We thank Ellen Karle and Betry Cook for 
their excellent technical assistance. 
met criteria for a diagnosis of HD,  the significance of 
the findings in this case would be undiminished. The 
absence of striatal cell loss and gliosis on routine neuro- 
pathological examination indicates that the subject 210:561-564 
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